Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
C. Caney, G. Singh, H. Lukka & A. J. Rainbow. (2004) Combined gamma‐irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin. International Journal of Radiation Biology 80:4, pages 291-299.
Read now
Read now
G. P. Raaphorst, H. Yang, D. E. Wilkins & C. E. Ng. (1996) Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and resistant glioma cell lines. International Journal of Hyperthermia 12:6, pages 801-812.
Read now
Read now
Articles from other publishers (18)
Daria Molodtsova, Denis V. Guryev & Andreyan N. Osipov. (2023) Composition of Conditioned Media from Radioresistant and Chemoresistant Cancer Cells Reveals miRNA and Other Secretory Factors Implicated in the Development of Resistance. International Journal of Molecular Sciences 24:22, pages 16498.
Crossref
Crossref
C. V. Guthier, A. V. D'Amico, M. T. King, P. L. Nguyen, P. F. Orio, S. Sridhar, G. M. Makrigiorgos & R. A. Cormack. (2018) Determining optimal eluter design by modeling physical dose enhancement in brachytherapy. Medical Physics 45:8, pages 3916-3925.
Crossref
Crossref
Chuanben Chen, Taojun Chen, Chaoxiong Huang, Jing Wang & Zhaodong Fei. (2017) Experience of weekly cisplatin concurrent with intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma patients with resistance to neoadjuvant chemotherapy. Medicine 96:44, pages e8434.
Crossref
Crossref
Lei Cui, Sohyoung Her, Michael Dunne, Gerben R. Borst, Raquel De Souza, Robert G. Bristow, David A. Jaffray & Christine Allen. (2017) Significant Radiation Enhancement Effects by Gold Nanoparticles in Combination with Cisplatin in Triple Negative Breast Cancer Cells and Tumor Xenografts. Radiation Research 187:2, pages 147-160.
Crossref
Crossref
Catherine R. Sears & John J. Turchi. (2012) Complex Cisplatin-Double Strand Break (DSB) Lesions Directly Impair Cellular Non-Homologous End-Joining (NHEJ) Independent of Downstream Damage Response (DDR) Pathways. Journal of Biological Chemistry 287:29, pages 24263-24272.
Crossref
Crossref
Robert A. Cormack, Srinivas Sridhar, W. Warren Suh, Anthony V. D'Amico & G. Mike Makrigiorgos. (2010) Biological in situ Dose Painting for Image-Guided Radiation Therapy Using Drug-Loaded Implantable Devices. International Journal of Radiation Oncology*Biology*Physics 76:2, pages 615-623.
Crossref
Crossref
Rathindra N. Bose, Leila Maurmann, Robert J. Mishur, Linda Yasui, Shefalika Gupta, W. Scott Grayburn, Heike Hofstetter & Tara Salley. (2008) Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum–phosphato complexes towards human ovarian cancer cells. Proceedings of the National Academy of Sciences 105:47, pages 18314-18319.
Crossref
Crossref
Heather J. Boeckman, Kelly S. Trego & John J. Turchi. (2005) Cisplatin Sensitizes Cancer Cells to Ionizing Radiation via Inhibition of Nonhomologous End Joining. Molecular Cancer Research 3:5, pages 277-285.
Crossref
Crossref
Ravi D. Rao, Sunil Krishnan, Tom R. Fitch, Paula J. Schomberg, Robert P. Dinapoli, Kathleen Nordstrom, Bernd Scheithauer, Judith R. O'Fallon, Matthew J. Maurer & Jan C. Buckner. (2005) Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): Results of North Central Cancer Treatment Group trial 98-72-51. International Journal of Radiation Oncology*Biology*Physics 61:2, pages 380-386.
Crossref
Crossref
Chris van Bree, Natasja Castro Kreder, Willem J.P Loves, Nicolaas A.P Franken, Godefridus J Peters & Jaap Haveman. (2002) Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines. International Journal of Radiation Oncology*Biology*Physics 54:1, pages 237-244.
Crossref
Crossref
Stefano Mastrangelo, Assunta Tornesello, Vincenzo Bembo, Vittoria Rufini & Renato Mastrangelo. (2000) Radioresistant sensitization of neuroblastoma by cisplatin?. Medical and Pediatric Oncology 35:1, pages 77-79.
Crossref
Crossref
Martin Kupiec. (2000) Damage-induced recombination in the yeast Saccharomyces cerevisiae. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 451:1-2, pages 91-105.
Crossref
Crossref
J.-A. Dolling, D.R. Boreham, D.L. Brown, G.P. Raaphorst & R.E.J. Mitchel. (1999) Cisplatin-modification of DNA repair and ionizing radiation lethality in yeast, Saccharomyces cerevisiae. Mutation Research/DNA Repair 433:2, pages 127-136.
Crossref
Crossref
S. Vincent Rajkumar, Jan C. Buckner, Paula J. Schomberg, Henry C. PitotIVIV, James N. Ingle & Terrence L. Cascino. (1999) Phase I Evaluation of Preirradiation Chemotherapy with Carmustine and Cisplatin and Accelerated Radiation Therapy in Patients with High-grade Gliomas. Neurosurgery 44:1, pages 67-73.
Crossref
Crossref
Catherine Lochrin, Glenwood Goss, David J. Stewart, Peter Cross, Olusegun Agboola, Simone Dahrouge, Eva Tomiak & W.K. Evans. (1999) Concurrent chemotherapy with hyperfractionated accelerated thoracic irradiation in stage III non-small cell lung cancer. Lung Cancer 23:1, pages 19-30.
Crossref
Crossref
S.Vincent Rajkumar, Jan C Buckner, Paula J Schomberg, Joel M Reid, Pamela J Bagniewski, Matthew M Ames, Terrence L Cascino & Randolph S Marks. (1998) Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma. International Journal of Radiation Oncology*Biology*Physics 42:5, pages 969-975.
Crossref
Crossref
Thomas Bjö>rk-Eriksson, Catharine West, Ewa Karlsson & Claes Mercke. (1998) Discrimination of human tumor radioresponsiveness using low-dose rate irradiation. International Journal of Radiation Oncology*Biology*Physics 42:5, pages 1147-1153.
Crossref
Crossref
Philippe Frit, Patrick Calsou, David J Chen & Bernard Salles. (1998) Ku70/Ku80 protein complex inhibits the binding of nucleotide excision repair proteins on linear DNA in vitro. Journal of Molecular Biology 284:4, pages 963-973.
Crossref
Crossref